Data Science Funding Announcements & Notices

Data science and informatics funding announcements and notices are available from NCI and NIH programs. Browse below for opportunities, requests for information, notices, and initiatives.

Title FOA Organization Release Date Expire Date Purpose
NCI Request for Information (RFI): Input on Development of an NCI Cancer Biomarker Data Aggregator NOT-CA-18-095 NCI N/A NCI Request Information RFI): Input Development an NCI Cancer Biomarker Data Aggregator Notice Number: NOT-CA-18-095 Key Dates Release Date: July 23, 2018 Response Date: October 20, 2018 Related… More
Feasibility Studies to Build Collaborative Partnerships in Cancer Research (P20 Clinical Trial Not Allowed) PAR-22-239 NCI Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites P20 planning grant applications for developing collaborative partnership between institutions serving… More
Notice of Availability of Administrative Supplements for Geospatial, Multilevel, and Contextual Approaches in Cancer Control and Population Sciences NOT-CA-19-029 NCI N/A Notice Availability Administrative Supplements Geospatial, Multilevel, Contextual Approaches Cancer Control Population Sciences Notice Number: NOT-CA-19-029 Key Dates Release Date: March 12, 2019… More
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional) RFA-CA-23-011 NCI The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called "competing revisions") from currently funded NCI U2C Resource-Related Multi… More
Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R01 Clinical Trial Not Allowed) PAR-22-139 NCI The purpose of this Funding Opportunity Announcement (FOA) is to solicit R01 research projects utilizing state-of-the-art cancer biology methods and model systems to study effects of different types… More
Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional) PAR-22-174 NCI The purpose of this FOA is to facilitate well planned clinical trials across the cancer prevention and control spectrum aimed at improving prevention/ interception, cancer-related health behaviors,… More
NCI Transition Career Development Award to Promote Diversity (K22 Independent Clinical Trial Not Allowed) PAR-21-301 NCI The purpose of the NCI Transition Career Development Award to Promote Diversity (K22) is to assist postdoctoral fellows or individuals in equivalent positions to transition to positions of assistant… More
Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R01 Clinical Trial Not Allowed) PAR-22-085 NCI This Funding Opportunity Announcement (FOA) solicits grant applications proposing to utilize bacteria, archaebacteria, bacteriophages, or other non-oncolytic viruses and their natural products to… More
Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional) PAR-21-321 NCI This Funding Opportunity Announcement (FOA) invites applications for P30 Cancer Center Support Grants (CCSGs) to support NCI-designated Cancer Centers. CCSGs support three types of Cancer Centers: 1… More
Basic Research in Cancer Health Disparities (R03 Clinical Trial Not Allowed) PAR-21-324 NCI This Funding Opportunity Announcement (FOA) encourages grant applications from investigators interested in conducting basic, mechanistic research into the biological/genetic causes of cancer health… More
Updated:
Vote below about this page’s helpfulness.
CAPTCHA Image CAPTCHA

Enter the characters shown in the image.